Royalty Pharma (RPRX)
(Delayed Data from NSDQ)
$27.49 USD
+0.32 (1.18%)
Updated Aug 19, 2024 04:00 PM ET
After-Market: $27.48 -0.01 (-0.04%) 7:58 PM ET
3-Hold of 5 3
B Value C Growth A Momentum B VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/13/2024
Time: -- |
9/2024 | $0.94 | 0.00% |
Earnings Summary
For their last quarter, Royalty Pharma (RPRX) reported earnings of $0.96 per share, beating the Zacks Consensus Estimate of $0.95 per share. This reflects a positive earnings surprise of 1.05%. Look out for RPRX's next earnings release expected on November 13, 2024. For the next earning release, we expect the company to report earnings of $0.94 per share, reflecting a year-over-year increase of 18.99%.
Earnings History
Price & Consensus
Zacks News for RPRX
Royalty Pharma (RPRX) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
RPRX: What are Zacks experts saying now?
Zacks Private Portfolio Services